Mundipharma
-
Cashing in on a cure: affiliate of Oxycontin-maker sets sights on naloxone marketMundipharma’s antidote, a naloxone nasal spray called Nyxoid, was recently approved in New Zealand, Europe and Australia.HealthDec 15, 2019
-
Mundipharma allegedly using fake doctors, misleading claims to drive OxyContin sales in ChinaAnother company owned by the Sackler family - makers of OxyContin - has used misleading claims and drug reps dressed up as doctors to peddle its signature painkiller in ChinaWorldNov 20, 2019
Trending
-
Meet the man who’s lived 30 years in Stanley Park46,070 Read
-
Woman who wheeled a corpse into bank to co-sign a loan arrested34,799 Read
-
All 787 Dreamliners should be grounded, Boeing whistleblower says28,881 Read
-
Uber driver shot, killed by 81-year-old after both received scam calls17,739 Read
-
Gas prices surge in some parts of Canada. What’s causing pain at the pumps?11,362 Read
-
Election interference worse than government admits, rights coalition says8,383 Read
-